Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)
CNY 2.69
(-0.74%)
CNY 2.69
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.58 Billion | 3.1 Billion | 3.14 Billion | 3.05 Billion | 5.05 Billion | 5.48 Billion |
| Cost of Revenue | 1.11 Billion | 719.21 Million | 829.69 Million | 793 Million | 1.34 Billion | 1.39 Billion |
| Gross Profit | 1.47 Billion | 2.38 Billion | 2.31 Billion | 2.26 Billion | 3.7 Billion | 4.08 Billion |
| Operating Expenses | 1.35 Billion | 2.25 Billion | 2.13 Billion | 2.27 Billion | 3.26 Billion | 3.45 Billion |
| Selling, General and Administrative Expenses | 1.24 Billion | 2.11 Billion | 2.02 Billion | 2.09 Billion | 2.98 Billion | 3.21 Billion |
| Research and Development Expenses | 91.25 Million | 100.63 Million | 97.73 Million | 125.48 Million | 185.78 Million | 122.93 Million |
| Other Expenses | 46.65 Million | 39.54 Million | 17.87 Million | 57.56 Million | 95.7 Million | 6.87 Million |
| Cost and Expenses | 2.45 Billion | 2.97 Billion | 2.96 Billion | 3.07 Billion | 4.6 Billion | 4.84 Billion |
| Operating Income | 175.04 Million | -111.54 Million | 156.56 Million | 784.65 Million | 320.25 Million | 172.06 Million |
| Interest Expense | 42.65 Million | 68.66 Million | 71.48 Million | 88.54 Million | 145.98 Million | 156.3 Million |
| Income Tax Expense | 48.07 Million | 19.83 Million | 32.13 Million | 156.44 Million | 50.8 Million | 50.16 Million |
| Earnings before Tax | 176.77 Million | -269.67 Million | 85.97 Million | 565.11 Million | -2.6 Billion | 178.93 Million |
| Net Income | 120.33 Million | -289.51 Million | 45.04 Million | 400.04 Million | -2.65 Billion | 125.89 Million |
| Earnings Per Share Basic | 0.05 | -0.13 | 0.02 | 0.18 | -1.21 | 0.06 |
| Earnings Per Share Diluted | 0.05 | -0.13 | 0.02 | 0.18 | -1.21 | 0.06 |
| Weighted Average Shares Outstanding | 2.19 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.19 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion |
| Gross Margin | 0.57 | 0.77 | 0.74 | 0.74 | 0.73 | 0.75 |
| EBIT Margin | 0.11 | 0.01 | 0.10 | 0.31 | 0.10 | 0.15 |
| Profit Margin | 0.05 | -0.09 | 0.01 | 0.13 | -0.53 | 0.02 |
| EBITDA | 275.28 Million | 18.5 Million | 301.95 Million | 818.85 Million | -2.23 Billion | 519.52 Million |
| Earnings Before Tax Margin | 0.07 | -0.04 | 0.05 | 0.26 | 0.06 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 636.19 Million | 618.15 Million | 586.07 Million | 2.58 Billion | 566.17 Million | 619.34 Million |
| Cost of Revenue | 306.98 Million | 292.04 Million | 273.97 Million | 1.11 Billion | 655.07 Million | 138.01 Million |
| Gross Profit | 329.21 Million | 326.11 Million | 312.1 Million | 1.47 Billion | -88.9 Million | 481.32 Million |
| Operating Expenses | 267.6 Million | 253.27 Million | 270.47 Million | 1.3 Billion | 26.85 Million | 402.16 Million |
| Selling, General and Administrative Expenses | 250.15 Million | 239.87 Million | 255.77 Million | - | -156.88 Million | 434.76 Million |
| Research and Development Expenses | 20.65 Million | 12.81 Million | 14.7 Million | - | 24.04 Million | 23.54 Million |
| Other Expenses | -3.2 Million | -585.23 Thousand | -35.49 Thousand | -3.2 Million | -2.81 Million | 13.99 Million |
| Cost and Expenses | 574.58 Million | 545.31 Million | 544.44 Million | 2.42 Billion | 681.45 Million | 540.18 Million |
| Operating Income | 69.03 Million | 72.83 Million | 41.62 Million | 166.91 Million | -115.75 Million | 209.03 Million |
| Interest Expense | 992.76 Thousand | 2.5 Million | 5.23 Million | 42.65 Million | 8.1 Million | 8.67 Million |
| Income Tax Expense | 8.72 Million | 8.89 Million | 12.65 Million | 48.07 Million | 18.94 Million | 10.03 Million |
| Earnings before Tax | 68.98 Million | 84.81 Million | 67.72 Million | 221.32 Million | 33.29 Million | 208.81 Million |
| Net Income | 58.51 Million | 72.68 Million | 52.28 Million | 120.33 Million | -103.28 Million | 195.37 Million |
| Earnings Per Share Basic | 0.03 | 0.03 | 0.02 | - | -0.05 | 0.09 |
| Earnings Per Share Diluted | 0.03 | 0.03 | 0.02 | - | -0.05 | 0.09 |
| Weighted Average Shares Outstanding | 2.28 Billion | 2.27 Billion | 2.27 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion |
| Weighted Average Shares Outstanding (Diluted) | 2.28 Billion | 2.27 Billion | 2.27 Billion | 2.19 Billion | 2.19 Billion | 2.19 Billion |
| Gross Margin | 0.52 | 0.53 | 0.53 | 0.57 | -0.16 | 0.78 |
| EBIT Margin | 0.11 | 0.16 | 0.14 | - | -0.16 | 0.38 |
| Profit Margin | 0.09 | 0.12 | 0.09 | 0.05 | -0.18 | 0.32 |
| EBITDA | 69.98 Million | 95.89 Million | 84.52 Million | - | -89.39 Million | 234.92 Million |
| Earnings Before Tax Margin | 0.11 | 0.12 | 0.07 | 0.06 | -0.20 | 0.34 |
0881
GLP-PB
GRCU
001560
0FGL
FLO